The effect of angiotensin-converting enzyme inhibitor on hemodynamic instability in patients undergoing cardiopulmonary bypass: Results of a dose-comparison study

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 14, Issue 3, 2009, Pages 185-191

  Shahzamani, Mehran ^a   Yousefi, Zohreh ^d,e   Frootaghe, Azam Noori ^a   Jafarimehr, Elnaz ^a   Froughi, Mahnoosh ^a   Tofighi, Farhood ^a,b,c   Azadani, Ali N ^f   Pourhoseingholi, Mohamad Amin ^e   Azadani, Peyman Nejatbakhsh ^a,b  

^a Cardiovascular Surgery Department

^b Department of Anesthesiology ^*  (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Torfe Hospital

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin; Coronary artery bypass graft; Hypotension

Indexed keywords

CAPTOPRIL; PHENYLEPHRINE;

ADULT; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HEART RATE; HEMODYNAMICS; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OPERATING ROOM; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 69949102132     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/1074248409341879     Document Type: Article

References (24)

1. Unger T., Stoppelhaar M. Rationale for double renin-angiotensin- aldosterone system blockade. Am J Cardiol. 2007 ; 100 (3A). 25-31.
2. Comfere T., Sprung J., Kumar MM, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg. 2005 ; 100 (3). 636-644.
3. Pigott DW, Nagle C., Allman K., Westaby S., Evans RD Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements. Br J Anaesth. 1999 ; 83 (5). 715-720.
4. Brabant SM, Bertrand M., Eyraud D., Darmon PL, Coriat P. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonist. Anesth Analg. 1999 ; 89 (6). 1388-1392.
5. Lee YK, Na SW, Kwak YL, Nam SB Effect of preoperative angiotensin-converting enzyme inhibitors on haemodynamic parameters and vasoconstrictor requirements in patients undergoing off-pump coronary artery bypass surgery. J Int Med Res. 2005 ; 33 (6). 693-702.
6. Tuman KJ, McCarthy RJ, O'Connor CJ, Holm WE, Ivankovich AD Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg. 1995 ; 80 (3). 473-479.
7. Carrel T., Englberger L., Mohacsi P., Neidhart P., Schmidli J. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg. 2000 ; 15 (5). 347-353.
8. Reich DL, Bodian CA, Krol M., Kuroda M., Osinski T., Thys DM Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg. 1999 ; 89 (4). 814-822.
9. Rychwaert F., Colson P. Hemodynamic effects of anesthesia in patients with ischemic heart failure chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg. 1997 ; 84 (5). 945-949.
10. Bertrand M., Godet G., Meersschaert K., Brun L., Salcedo E., Coriat P. Should the angiotensin II antagonists be discontinued before surgery ? Anesth Analg. 2001 ; 92 (1). 26-30.
11. Lazar HL All coronary artery bypass graft surgery patients will benefit from angiotensin-converting enzyme inhibitors. Circulation. 2008 ; 117 (1). 6-8.
12. Jain U., Laflamme CJ, Aggarwal A., et al. Electrocardiographic and hemodynamic changes and their association with myocardial infarction during coronary artery bypass surgery. A multicenter study. Multicenter Study of Peri-operative Ischemia (McSPI) Research Group. Anesthesiology. 1997 ; 86 (3). 576-591.
13. Gold JP, Charlson ME, Williams-Russo P., et al. Improvement of outcomes after coronary artery bypass: a randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995 ; 110 (5). 1302-1314.
14. Licker M., Neidhart P., Lustenberger S., et al. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery. Anesthesiology. 1996 ; 84 (4). 789-800.
15. Bottcher M., Behrens JK, Moller EA, Christensen JH, Andreasen F. ACE inhibitor premedication attenuates sympathetic responses during surgery. Br J Anaesth. 1994 ; 72 (6). 633-637.
16. Khairallah PA Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake. Fed Proc. 1972 ; 31 (4). 1351-1357.
17. Giudicelli JF, Berdequx A., Edouard A., Richer C., Jacolot D. The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol. 1985 ; 20 (3). 211-218.
18. Williams GH Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med. 1988 ; 319 (23). 1517-1525.
19. Licker M., Schweizer A., Hohn L., Morel DR Chronic angiotensin converting inhibition does not influence renal hemodynamic and function during cardiac surgery. Can J Anaesth. 1999 ; 46 (7). 626-634.
20. Nakamaru M., Inagami T. Atrial natriuretic factor inhibits norepinephrine release evoked by sympathetic nerve stimulation in isolated perfused rat mesenteric arteries. Eur J Pharmacol. 1986 ; 123 (3). 459-461.
21. Colson P., Ryckwaert F., Coriat P. Renin angiotensin system antagonists and anesthesia. Anesth Analg. 1999 ; 89 (5). 1143-1155.
22. Christakis GT, Fremes SE, Koch JP, et al. Determinants of low systemic vascular resistance during cardiopulmonary bypass. Ann Thorac Surg. 1994 ; 58 (4). 1040-1049.
23. Kristof AS, Magder S. Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass. Crit Care Med. 1999 ; 27 (6). 1121-1127.
24. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: clinical applications. JAMA. 2002 ; 287 (11). 1445-1447.